HML-1, A Novel Integrin Made of the β7 Chain and of a Distinctive α Chain, Exerts an Accessory Function in the Activation of Human IEL via the CD3-TCR Pathway

  • Bernadette Bègue
  • Sabine Sarnacki
  • Françoise le Deist
  • Hélène Buc
  • Jean Gagnon
  • Tomaso Méo
  • Nadine Cerf-Bensussan
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 371)

Abstract

Intestinal intraepithelial lymphocytes (EEL) form a large population of T cells located at the interface between the body and the intestinal lumen. They differ from T cells in other lymphoid compartments by their phenotype, mainly CD3+CD8+, the elevated proportion of TcR gd+ cells, their dual thymo-dependent and -independent origin, their cytotoxic properties and their microenvironment in the immediate vicinity of epithelial cells, at some distance from the usual partners of the immune response.1,2 The hypothesis that IEL possess specific surface receptors enabling interactions with local ligands and controlling their homing, differentiation and/or activation, led us to seek membrane antigens expressed on IEL but not on lymphocytes in other lymphoid organs. One monoclonal antibody, HML-1, raised against human IEL defined a novel membrane antigen preferentially expressed by IEL in the human intestine and in other epithelia (that we will hereafter refer to as MLA for mucosal lymphocyte antigen). Interestingly, in humans, the antibody HML-1 was found to label rare intestinal T cell lymphomas associated with an enteropathy and hyperplasia of IEL, sustaining a previous hypothesis of the intraepithelial origin of such lymphomas4 and HML-1 labelling was also observed on abnormal cells in mycosis fungoides with marked epidermotropism.5 However, the expression of this membrane antigen was not entirely restricted to normal or tumoral IEL as it appeared on activated T cells, mainly CD8+6,7 Furthermore, HML-1 labelling appeared to be an almost constant phenotypical feature of hairy B cell leukemia.7-9 In spite of this not entirely specific expression, the antigen defined by HML-1 seemed to be an interesting antigen and a potential candidate for mediating interactions between IEL and enterocytes.

Keywords

Migration HPLC Lymphoma Leukemia Cysteine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    N. Cerf-Bensussan and D.Guy-Grand, Gastroenterol. Clin. N. Amer. 20: 549 (1991).Google Scholar
  2. 2.
    D. Guy-Grand, N. Cerf-Bensussan, B. Malissen, M. Malassis-Seris, C. Briottet, and P. Vassalli, J. Exp. Med. 173: 471 (1991).PubMedCrossRefGoogle Scholar
  3. 3.
    N. Cerf-Bensussan, A. Jarry, N. Brousse, B. Lisowska-Grospierre, D. Guy-Grand, and C.Griscelli, Eur. J. Immunol. 17: 1279 (1987).PubMedCrossRefGoogle Scholar
  4. 4.
    J. Spencer, N. Cerf-Bensussan, A. Jarry, N. Brousse, D. Guy-Grand, A. S. Krajewski, and P. Isaacson, Am. J. Pathol. 132: 1 (1988).PubMedGoogle Scholar
  5. 5.
    M. Sperling, P. Kaudewitz, O. Braun-Falco, H. Stein, Am. J. Pathol. 134: 955 (1989).PubMedGoogle Scholar
  6. 6.
    H. L. Schieferdecker, R. Ullrich, B. A.Weiss, R. Schwarting, H. Stein, E. O. Riecken, and M. Zeitz, J. Immunol. 144: 2541 (1990).Google Scholar
  7. 7.
    M. Kruschwitz, G. Fritsche, R. Schwarting, H. Dürkop, K. Micklem, D.Y. Mason, B. Falini, and H. Stein, J. Clin. Pathol. 44: 636 (1991).PubMedCrossRefGoogle Scholar
  8. 8.
    P. Möller, B. Mielke, and G. Moldenhauer, Am. J. Pathol. 136: 509 (1990).PubMedGoogle Scholar
  9. 9.
    L. Flenghi, F. Spinozzi, H. Stein, M. Kruschwitz, S. Pileri, and B. Falini, Br. J. Haematol. 76: 451 (1990).PubMedCrossRefGoogle Scholar
  10. 10.
    R.O. Hynes, Cell 69: 11 (1992).CrossRefGoogle Scholar
  11. 11.
    Y. Shimizu, G. A. Van Seventer, K. J. Horgan, and S. Shaw, Immunol. Rev. 109: 43 (1990).Google Scholar
  12. 12.
    G. A. Van Seventer, W. Newman, Y. Shimizu, T. B. Nutman, Y. Tanaka, K. J. Horgan, T. V. Gopal, E. Ennis, D. O’Sullivan, H. Grey, and S. Shaw, J. Exp. Med. 174: 901 (1991).PubMedCrossRefGoogle Scholar
  13. 13.
    S. Sarnacki, B. Bègue, H. Buc, F. Le Deist, and N. Cerf-Bensussan, Eur. J. Immunol. 22: 2887 (1992).PubMedCrossRefGoogle Scholar
  14. 14.
    N. Cerf-Bensussan, B. Bègue, J. Gagnon, and T. Mèo, Eur. J. Immunol. 21:273 and 885 (1992).Google Scholar
  15. 15.
    N. Cerf-Bensussan, D. Guy-Grand, and C. Griscelli, Gut 26: 81 (1985).PubMedCrossRefGoogle Scholar
  16. 16.
    A. Jarry, N. Cerf-Bensussan, N. Brousse, F. Selz, and D. Guy-Grand, Eur. J. Immunol. 20: 1097 (1990).PubMedCrossRefGoogle Scholar
  17. 17.
    Q. Yuan, W. M. Jiang, G. W. Krissansen, and J. D.Watson, Int. Immunol. 2: 1097 (1990).PubMedCrossRefGoogle Scholar
  18. 18.
    D. J. Erie, C. Ruëgg, D. Sheppard, and R. Pytela, J. Biol Chem. 266: 11009 (1991).Google Scholar
  19. 19.
    M. E. Hemler, M. J. Elices, C. Parker, and Y. Takada, Immunol Rev. 114: 45 (1990).PubMedCrossRefGoogle Scholar
  20. 20.
    P. J. Kilshaw and S. J. Murrant, Eur. J. Immunol 20: 2201 (1990).PubMedCrossRefGoogle Scholar
  21. 21.
    C. M. Parker, K. L. Cepek, G. J. Russell, S. K. Shaw, D. N. Posnett, R. Schwarting, and M. B. Brenner, Proc. Natl Acad. Sci. USA 89: 1924 (1992).PubMedCrossRefGoogle Scholar
  22. 22.
    F. A. Harding, J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison, Nature 356: 607 (1992).PubMedCrossRefGoogle Scholar
  23. 23.
    N. Cerf-Bensussan, D. Guy-Grand, B. Lisowska-Grospierre, C. Griscelli, and A. K. Bhan, J. Immunology 136: 76 (1986).Google Scholar
  24. 24.
    K. J. Micklem, Y. Dong, A. Willis, K. A. Pulford, L. Visser, H. Dürkop, S. Poppema, H. Stein, and D. Y. Mason, Am. J. Pathol 139: 1297 (1991).PubMedGoogle Scholar
  25. 25.
    Q. Yuan, W.-M. Jiang, E. Leung, D. Hollander, J. D. Watson, G. W. Krissansen, J. Biol Chem. 267: 7352 (1992).PubMedGoogle Scholar
  26. 26.
    G. A. Ksander, C. O. Gerhardt, J. R. Dasch, and L. R. Ellinsworth, J. Histochem. Cytochem. 38: 1831 (1990).PubMedCrossRefGoogle Scholar
  27. 27.
    B. B. Holzmann, W. Mclntyre, and I. L.Weissman, Cell 48: 549 (1989).Google Scholar
  28. 28.
    B.B. Holzmann and I. L. Weissman, EMBO J. 8: 735 (1990).Google Scholar
  29. 29.
    C. Lucas, L. N. Bald, B. M. Fendly, M. Mora-Worms, I. S. Figari, E. J. Patzer, and M. A. Palladino, J. Immunol 145: 1415 (1990).PubMedGoogle Scholar
  30. 30.
    K. Miyake, I. L. Weissman, J. S. Greenberger, and P. W. Kincade, J. Exp. Med. 173: 599 (1991).PubMedCrossRefGoogle Scholar
  31. 31.
    S. Nonoyama, M. Nakayama, T. Shiohara, and J. Yata, Eur. J. Immunol 19: 1631 (1989).PubMedCrossRefGoogle Scholar
  32. 32.
    N. Cerf-Bensussan, A. Jarry, T. Gnéragbé, N. Brousse, B. Lisowska-Grospierre, C. Griscelli, and D. Guy-Grand, Monogr. Allergy 24: 167 (1988).PubMedGoogle Scholar
  33. 33.
    R. H. Schwartz, Science 248: 1349 (1990).CrossRefGoogle Scholar
  34. 34.
    C. J. Smart, A. Calabrese, D. J. Oakes, P. D. Howdle, and L. K. Tredjdosiewicz, Scand. J. Immunol 34: 299 (1991).PubMedCrossRefGoogle Scholar
  35. 35.
    A. I. Roberts, S. M. O’Connell, and E. C. Ebert, DDW Scientific Sessions San Francisco May 10–13 Abstract 976 (1992).Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Bernadette Bègue
    • 1
  • Sabine Sarnacki
    • 1
  • Françoise le Deist
    • 1
  • Hélène Buc
    • 2
  • Jean Gagnon
    • 3
  • Tomaso Méo
    • 4
  • Nadine Cerf-Bensussan
    • 1
  1. 1.Hôpital Necker-Enfants MaladesINSERM U132ParisFrance
  2. 2.Faculté NeckerINSERM U75France
  3. 3.Laboratoire de Biologie StructuraleCEA et CNRS URA 1333GrenobleFrance
  4. 4.Institut PasteurUnité d’immunogénetique et INSERM U276ParisFrance

Personalised recommendations